The company doses first patient in US study of Deraphan, as Dolby Ventures joins €53M Series B to support neuropsychiatric innovation
Former Novo Nordisk and Pharmanovia executive to lead next growth phase in NAD diagnostics and personalised health innovation
With big pharma leaning on external pipelines, the company sees opportunity in de-risked, high-impact assets with clear clinical endpoints
Hyderabad based 400-bed facility brings AI-driven care, advanced imaging, and integrated clinical systems under one roof
The company has supported the initiative since its inception, contributing to screening efforts in around 120 countries
Experts call for integrated, evidence-based approaches to tackle rising dengue, malaria, and chikungunya burden in Indian cities
The approval was driven by data from the Phase III TULIP-SC trial
nSEPIA aims to bring structure to an area long dominated by subjectivity
New model focuses on continuity of care, combining therapy, routine and social engagement to support long-term recovery
The summit brought together over 150 doctors, researchers, and practitioners worldwide
Subscribe To Our Newsletter & Stay Updated
